| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Illumina, Inc. (ILMN) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 31 sells. ILMN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.50M | $565.17M | - | |
| Dir | 2.83M | $456.78M | -669,596 | |
| CEO | 82.1K | $13.25M | - | |
| VP | 41.9K | $6.77M | - | |
| VP | 33.0K | $5.33M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 12, 2018 | Flatley Jay T47 | Director | Sell | 3,300 | $334.13 | $1,102,629.00 | -0.9% | |
| Dec 10, 2018 | Ostadan Omead81 | EVP Ops, Products, Strategy | Sell | 644 | $321.50 | $207,046.00 | -2.9% | |
| Dec 6, 2018 | Stapley Marc60 | EVP Strategy &Corp Developmt | Sell | 1,000 | $329.69 | $329,694.50 | -2.2% | |
| Dec 3, 2018 | Desouza Francis A | President And CEO | Sell | 3,000 | $345.90 | $1,037,688.00 | -0.8% | |
| Dec 3, 2018 | Dadswell Charles82 | Sr VP &General Counsel | Sell | 566 | $343.57 | $194,460.62 | -9.2% | |
| Dec 3, 2018 | Epstein Robert S | Director | Sale+OE | 1,345 | $343.57 | $462,101.65 | -22.0% | |
| Nov 28, 2018 | Flatley Jay T47 | Director | Sell | 3,300 | $321.80 | $1,061,940.00 | -0.9% | |
| Nov 23, 2018 | Ostadan Omead81 | EVP Ops, Products, Strategy | Sell | 644 | $306.74 | $197,540.56 | -2.8% | |
| Nov 14, 2018 | Flatley Jay T47 | Director | Sell | 3,300 | $312.50 | $1,031,250.00 | -0.9% | |
| Nov 12, 2018 | Ronaghi Mostafa | Sr VP &CTO | Sale+OE | 10,000 | $314.63 | $3,146,336.99 | -1.1% |